Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis

Journal of Crohn's and Colitis

Volumn 8, Issue 12, 2014, Pages 1569-1581

  Colman, Ruben J ^a,b   Rubin, David T ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Fecal microbiota transplantation; Inflammatory bowel disease; Meta analysis; Microbiome; Mucosal healing; Systematic review

Indexed keywords

FECES; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; META ANALYSIS; MICROBIOLOGY; MICROFLORA; PROCEDURES; REMISSION; TRANSPLANTATION;

FECES; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICROBIOTA; REMISSION INDUCTION; TRANSPLANTATION;

EID: 84918584474     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.08.006     Document Type: Review

References (45)

1. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415.
2. Bennet J.D., Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989, 1:164.
3. Borody T.J., Campbell J., Torres M., Nowak A., Leis S. Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT]. Am J Gastroenterol 2011, 106:S352.
4. Borody T.J., George L., Andrews P., Brandl S., Noonan S., Cole P., et al. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?. Med J Aust 1989, 150:604.
5. Borody T.J., Leis S., McGrath K. Treatment of chronic constipation and colitis using human probiotic infusions. Probiotics, Prebiotics and New Foods Conference September 2-4 2001, Universita Urbaniana, Rome.
6. Borody T.J., M T, Campbell J., Leis S., Nowak A. Reversal of inflammatory bowel disease (IBD) with recurrent faecal microbiota transplants (FMT). Am J Gastroenterol 2011, 106:S366.
7. Borody T.J., Warren E.F., Leis S., Surace R., Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003, 37:42-47.
8. Kellermayer R., Nagy-Szakal D., Mir S.A., Luna R.A., Pitashny M., Hollister E., et al. Complex bacteriotherapy in pediatric gastrointestinal disorders. J Pediatr Gastroenterol Nutr 2013, 57:e66.
9. Kao D., Madsen K. Fecal microbiota transplantation (FMT) in the treatment of inflammatory bowel disease (IBD): a case report. Am J Gastroenterol 2013, 108:S415.
10. Anderson J.L., Edney R.J., Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012, 36:503-516.
11. Sha S., Liang J., Chen M., Xu B., Liang C., Wei N., et al. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther 2014, 39:1003-1032.
12. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
13. Wells G., Shea B., O'Connell D., Peterson J., Welch V., Losos M., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000.
14. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
15. Zhang F.-M., Wang H.-G., Wang M., Cui B.-T., Fan Z.-N., Ji G.-Z. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease. World J Gastroenterol 2013, 19:7213-7216.
16. Wallace B.C., Schmid C.H., Lau J., Trikalinos T.A. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009, 9:80.
17. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
18. Chapter 9: analysing data and undertaking meta-analyses. Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008] 2008, The Cochrane Collaboration. J. Deeks, J. Higgins, D. Altman, on behalf of the Cochrane Statistical Methods Group, The Cochrane Bias Methods Group (Eds.).
19. Wang M., Wang H., Zhang F. Standard fecal microbiota transplantation through mid-gut is effective therapy for refractory ulcerative colitis. J Gastroenterol Hepatol 2013, 28:590.
20. Angelberger S., Reinisch W., Makristathis A., Lichtenberger C., Dejaco C., Papay P., et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013, 108:1620-1630.
21. Damman C., Brittnacher M., Hayden H., Radey M., Hager K., Miller S., et al. Single colonoscopically administered fecal microbiota transplant for ulcerative colitis-a pilot study to determine therapeutic benefit and graft stability. Gastroenterology 2014, 146:S-460.
22. Kump P.K., Grochenig H.P., Lackner S., Trajanoski S., Reicht G., Hoffmann K.M., et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013, 19:2155-2165.
23. Kunde S., Pham A., Bonczyk S., Crumb T., Duba M., Conrad H., et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013, 56:597-601.
24. Landy J., Al-Hassi H.O., Mann E.R., Peake S.T., McLaughlin S.D., Ciclitira P.J. Tu1985 A prospective controlled pilot study of fecal microbiota transplantation for chronic refractory pouchitis. Gastroenterology 2013, 144:S-897.
25. Suskind D., Wahbeh G., Vendetoulli H., Singh N., Miller S. Fecal microbial transplant in pediatric Crohn's disease. Gastroenterology 2014, 146:S-834.
26. Vaughn B.P., Gevers D., Ting A., Korzenik J.R., Robson S.C., Moss A.C. Fecal microbiota transplantation induces early improvement in symptoms in patients with active Crohn's disease. Gastroenterology 2014, 146:S591-S592.
27. Vermeire S., Joossens M., Verbeke K., Hildebrand F., Kathleen M., Van den Broeck K., et al. Sa1922 Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn's disease. Gastroenterology 2012, 142:S-360.
28. Zhang F.-M., Wang H.-G., Wang M., Cui B.-T., Huang G., Ji G.-Z., et al. Standard fecal microbiota transplantation through mid-gut is an effective therapy of refractory Crohn's disease. J Gastroenterol Hepatol 2013, 28:9.
29. Moayyedi P., Surette M., Wolfe M., Taraschi R., Kim P., Libertucci J., et al. A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis. Gastroenterology 2014, 146:S-159.
30. Libertucci J., Whelan F.J., Moayyedi P., Lee C.H., Wolfe M., Onishi C., et al. Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial. Gastroenterology 2014, 146:S-902.
31. Grehan M.J., Borody T.J., Leis S.M., Campbell J., Mitchell H., Wettstein A. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010, 44:551-561.
32. Brandt L., Aroniadis O. Long-term follow-up study of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). Am J Gastroenterol 2012, 107:S657.
33. Borody T., Wettstein A., Campbell J., Leis S., Torres M., Finlayson S., et al. Fecal microbiota transplantation in ulcerative colitis: review of 24years experience. Am J Gastroenterol 2012, 107:S665.
34. Kirsner J.B. The historical basis of idiopathic inflammatory bowel diseases. Inflamm Bowel Dis 1995, 1:2-26.
35. Dasgupta S., Kasper D.L. Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease. Inflamm Bowel Dis 2013, 19:2478-2489.
36. Michail S., Durbin M., Turner D., Griffiths A.M., Mack D.R., Hyams J., et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 2012, 18:1799-1808.
37. Chassaing B., Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011, 140:1720-1728.
38. Kruis W., Fric P., Pokrotnieks J., lukás S.M., Fixa B., Kascák M., et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004, 53:1617-1623.
39. Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202-1209.
40. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004, 53:108-114.
41. Rubin D.T. Curbing our enthusiasm for fecal transplantation in ulcerative colitis. Am J Gastroenterol 2013, 108:1631-1633.
42. Koch R., Brock T. Die Aetiologie der Tuberkulose. Mittheilungen aus dem Laiserlichen Gesundheitsampte 1884, 2:1-88.
43. Consensus guidance on donor screening and stool testing for FMT 2013, volume 2014. ACG, AGA, ASGE, NASPGHAN, IDSA.
44. Kassam Z., Lee C.H., Yuan Y., Hunt R.H. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013, 108:500-508.
45. Cammarota G., Ianiro G., Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 2014, 48:693-702.